new IV antibiotic for methicillin-resistant Staph aureus (MRSA) infections, Vibativ (vy-BA-tiv)
November 2009
Please see the June 2013 FDA release regarding the expanded use of Vibativ
It's the first in a new class. But it's related to vancomycin...and has many of vanco's drawbacks.
Vibativ (telavancin) is only approved for complicated skin and skin structure infections in adults. It covers gram-positive bacteria, including MRSA.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote